Headlines

Gilead provides $7.6m in grants for health equity in breast cancer

The pharma company provides funding to 24 community organizations throughout the US, as part of its newly created ‘Toward Health Equity Oncology Grant’.

Interview: Arthur Wakeley, MD of Celadon, the first UK company cleared to make medical cannabis

As reported on January 17, Celadon Pharmaceuticals Plc was the first company to clear the regulations in the UK to make medical cannabis.

Aardex and Cambridge Cognition cooperate on decentralized trials

Aardex will provide adherence monitoring tools to Cambridge Cognition for use in hybrid and fully decentralized clinical trial services.

US FTC takes action against GoodRx for sharing sensitive health info

The commission took enforcement action for the first time under its Health Breach Notification Rule against GoodRx.

SCOPE 2023 - will decentralized trials be the hottest topic?

One of the biggest questions being posed at this year's SCOPE summit, is whether the term 'decentralized clinical trials' will become redundant, as it forms the norm.